Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
europe blog main
4
×
fda
4
×
life sciences
national blog main
san francisco blog main
boston top stories
cancer
clinical trials
europe top stories
national
national top stories
new york blog main
new york top stories
san francisco top stories
biogen
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
deals
deerfield management
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
What
ipo
4
×
medicines
new
bio
biotech
companies
covid
research
roundup
acquisitions
activity
announced
approvals
arrival
biogen
black
cancer
ceo
clamped
clinic
collabs
daniel
days
deal
delays
developing
diamond
drug
economic
eluded
fast
fda
gilead
gilead’s
hasn’t
help
hopes
including
industry
introduce
Language
unset
Current search:
fda
×
biotech
×
" europe blog main "
×
ipo
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
